1. CD73 activity and outcome of advanced melanoma patients treated with nivolumab. (March 2018) Authors: Morello, S.; Sorrentino, C.; Capone, M.; Giannarelli, D.; Madonna, G.; Mallardo, D.; Grimaldi, A.M.; Pinto, A.; Ascierto, P.A. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expression of CD73 on MDSCs and CD8+/PD-1+ cells as new possible biomarkers for advanced melanoma patients treated with nivolumab. (March 2018) Authors: Fratangelo, F.; Morello, S.; Madonna, G.; Capone, M.; Mallardo, D.; Falcone, R.; Grimaldi, A.M.; Simeone, E.; Vanella, V.; Giannarelli, D.; Sorrentino, C.; Pinto, A.; Ascierto, P.A. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗